Cefpirome sulfate exhibits a broad antibacterial spectrum, including activity against Gram-positive and Gram-negative cocci; it is particularly effective against Enterobacteriaceae that produce class I β-lactamases, which typically inactivate third-generation cephalosporins. It demonstrates stronger activity against methicillin-sensitive Staphylococcus aureus compared to third-generation cephalosporins and shows the highest potency among third- and fourth-generation cephalosporins against Gram-positive bacteria. It also displays excellent activity against enteric pathogens such as Salmonella spp., Shigella spp., Klebsiella spp., and Vibrio cholerae. Due to its potent bactericidal activity against pathogens causing bacterial meningitis and its ability to penetrate the blood-brain barrier, cefpirome sulfate is effective in the treatment of meningitis infections.